GlassScriptPhysician profile
Crystal F Totten
NPI 1740415736
$152,079.65
in general payments reported to CMS, 2019-2025
10 companies · $104K in 2025
The $104K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,376 · 2020: $2,398 · 2021: $2,512 · 2022: $1,258 · 2023: $1,427 · 2024: $38K · 2025: $104K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $108K · Travel and Lodging: $25K · Food and Beverage: $7,034 · Consulting Fee: $3,300 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $107,700.00 |
| Travel and Lodging | $25,493.34 |
| Food and Beverage | $7,033.74 |
| Consulting Fee | $3,300.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $144,434.75 | 2019-2025 | Phasix Mesh, Xenmatrix Ab Surgical Graft |
| Intuitive Surgical, INC. | $3,972.45 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $1,349.79 | 2020 | |
| Becton, Dickinson and Company | $637.86 | 2024 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $470.20 | 2022-2024 | Gore Enform Preperitoneal Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Cook Medical LLC | $398.33 | 2019-2020 | |
| Baxter Healthcare | $396.18 | 2019-2025 | Tisseel |
| Ethicon US, LLC | $250.80 | 2020-2025 | Monocryl, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Medtronic, INC. | $90.01 | 2021-2025 | Appose Ulc, Ligasure, Signia |
| Covidien LP | $79.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Totten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.